← Eichor
Condition: Hpv Related Malignancy Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Hpv Related Malignancy

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Dynamic ctDNA Assessment in Cervical and Anal Canal Tumors: Optimizing Follow-up and Clinical Outcomes
Phase 2 · 1 location(s) · Instituto do Cancer do Estado de São Paulo · NCT06640283Trial of Cemiplimab, or Cemip-Chemo Followed by Biomarker-guided Treatment for Pts w/HPV H&N Ca
Phase 2 · 1 location(s) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · NCT04988074The Sinai Robotic Surgery Trial in HPV-related Oropharyngeal Squamous Cell Carcinoma (SIRS 2.0 Trial)
Phase 2 · 2 location(s) · Icahn School of Medicine at Mount Sinai · NCT05419089Breast Cancer-Related Approach for Increasing Cervical Cancer Screening
NA · 1 location(s) · Jessica Di Vincenzo Sormani · NCT07171658De-Escalated Adjuvant and Definitive Radiation Therapy Informed by DART 2.0 ctHPV-DNA
Phase 2 · 3 location(s) · Mayo Clinic · NCT05541016Natural History, Epidemiology and Pathogenesis of Severe HPV-Related Diseases (Neptune)
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT05026138Trial in HPV Prevention for the U.S. Vietnamese Community
NA · 1 location(s) · Northwestern University · NCT07637630Developing a Combined Molecular Screening and Triage Test for Cervical Cancer in Self-samples
NA · 1 location(s) · Universiteit Antwerpen · NCT06598176A Phase III Clinical Trial of a 11-valent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha) in Chinese Wome
Phase 3 · 8 location(s) · National Vaccine and Serum Institute, China · NCT05262010A Study on Using Cell-Free Tumor DNA (ctDNA) Testing to Decide When to StartRoutine Treatment in People With Human Papil
Phase 2 · 8 location(s) · Memorial Sloan Kettering Cancer Center · NCT05307939Neoadjuvant Chemotherapy and Transoral Robotic Surgery for Oropharyngeal Cancer.
Phase 2 · 1 location(s) · Nader Sadeghi · NCT04277858Study on the Relationship Between Plasma MRD and cfDNA HPV and the Efficacy and Prognosis of Locally Advanced Cervical C
Phase N/A · 1 location(s) · Guizhou Provincial People's Hospital · NCT05950087The Minimalist Trial-2
Phase 2 · 3 location(s) · Washington University School of Medicine · NCT06702033A Study Comparing Personalized Radiation Therapy With Standard Radiation Therapy in People With HPV-Positive Throat Canc
Phase 3 · 9 location(s) · Memorial Sloan Kettering Cancer Center · NCT06563479Biomarker Approach to Screening for the Early Detection of HPV-related Oropharyngeal Cancer (BASH OPC)
Phase N/A · 2 location(s) · H. Lee Moffitt Cancer Center and Research Institute · NCT06305676Response Adaptive Radiotherapy Following Immunotherapy-based Induction for Non-HPV Related HNSCC
Phase 2 · 1 location(s) · Cancer Institute and Hospital, Chinese Academy of Medical Sc · NCT06345287Automated Cervical Cancer Screening Using a Smartphone-based Artificial Intelligence Classifier
NA · 1 location(s) · Prof. Patrick Petignat · NCT04859530Phase 1 Dose-escalation Study of FluBHPVE6E7 in HPV16-infected Women
Phase 1 · 1 location(s) · BlueSky Immunotherapies GmbH · NCT05829629Evaluating a Decreased Dose of Radiation Therapy to the Elective Neck for the Treatment of HPV-Related Oropharyngeal Can
Phase 2 · 2 location(s) · Northwestern University · NCT07178301The Women's Screening and Self-Testing Program (PROMETA) Study
NA · 1 location(s) · Tulane University · NCT06810739Comparison of 5-ALA Photodynamic Therapy and CO2 Laser for Treating Persistent Low-Grade Cervical Lesions With High-Risk
NA · 1 location(s) · First Affiliated Hospital of Wenzhou Medical University · NCT06052033Screening Women With Prior HPV for Anal Neoplasia
NA · 3 location(s) · Icahn School of Medicine at Mount Sinai · NCT05217940ReMARK: Addressing Disparities in Rural HPV-related Cancer Prevention
NA · 1 location(s) · University of Florida · NCT06535139Prognostic Value of Conization and Negative HPV After Conization in AIS and Early Stage Cervical Cancer
Phase N/A · 1 location(s) · Rambam Health Care Campus · NCT06196190Tongue-out Radiation Therapy (TORT) for the Mitigation of Radiotherapy-related Toxicities in Patients With Head and Neck
NA · 1 location(s) · Yvonne Mowery · NCT07227792PRGN-2009 in Combination With Pembrolizumab in Patients With Recurrent or Metastatic Cervical Cancer
Phase 2 · 3 location(s) · Precigen, Inc · NCT06157151Determining the Frequency of Occurrence and Defining the Most Appropriate Screening Test for Anal Intraepithelial Neopla
NA · 1 location(s) · PCK Marine Hospital in Gdynia · NCT06574087Feasibility of HPV Testing With Mail-delivered Sample Collection Kits
Phase N/A · 1 location(s) · University of California, San Francisco · NCT07087145E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers
Phase 2 · 3 location(s) · Christian Hinrichs · NCT05686226Remote Audiometry to Monitor for Treatment-Related Hearing Loss in Patients With H&N SCC Receiving Cisplatin and/or Radi
NA · 1 location(s) · Emory University · NCT06662058
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.